medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2020-8-144-152medsovet-5692Research ArticleРЕВМАТОЛОГИЯRHEUMATOLOGYМеждисциплинарный подход к ведению пациентов с хронической подагройInterdisciplinary approach to the management of patients with chronic gouthttps://orcid.org/0000-0001-8040-3704ЦуркоВ. В.TsurkoV. V.

Цурко Владимир Викторович, д.м.н., профессор кафедры общей врачебной практики Института последипломного образования; профессор кафедры факультетской терапии лечебного факультета

117997, Россия, Москва, ул. Островитянова, д. 1

119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2

Vladimir V. Tsurko, Dr. of Sci. (Med), Professor of the Department of General Medical Practice of the Institute of Postgraduate Education; Professor of the Department of Faculty Therapy of the Medical Faculty

1, Ostrovityanov St., Moscow, 117997, Russia

8, Bldg. 2, Trubetskaya St., Moscow, 119991, Russia

vvtsurko@mail.ruhttps://orcid.org/0000-0002-3757-058XГромоваМ. А.GromovaM. A.

Громова Маргарита Александровна, к.м.н., ассистент кафедры факультетской терапии лечебного факультета

117997, Россия, Москва, ул. Островитянова, д. 1

Margarita A. Gromova, Cand. of Sci. (Med.), Assistant Professor of the Department of Faculty Therapy of the Medical Faculty

1, Ostrovityanov St., Moscow, 117997, Russia

margarita-gromov@mail.ruhttps://orcid.org/0000-0002-3216-9412МалышеваН. В.MalyshevaN. V.

Малышева Наталья Всеволодовна, к.м.н., доцент кафедры факультетской терапии лечебного факультета

117997, Россия, Москва, ул. Островитянова, д. 1

Natalia V. Malysheva, Cand. of Sci. (Med.), Associate Professor of the Department of Faculty Therapy of the Medical Faculty

1, Ostrovityanov St., Moscow, 117997, Russia

malyshevan@inbox.ruРоссийский национальный исследовательский медицинский университет им. Н.И. Пирогова; Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)РоссияN.I. Pirogov Russian National Research Medical University; First Moscow State Medical University named after I.M. Sechenov (Sechenov University)Russian FederationРоссийский национальный исследовательский медицинский университет им. Н.И. ПироговаРоссияN.I. Pirogov Russian National Research Medical UniversityRussian Federation20201407202008144152Copyright © Цурко В.В., Громова М.А., Малышева Н.В., 20202020Цурко В.В., Громова М.А., Малышева Н.В.Tsurko V.V., Gromova M.A., Malysheva N.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/5692

Подагра, одна из наиболее распространенных форм воспалительного артрита, характеризуется сильной болью в суставах, которая часто мешает повседневной деятельности. В последние годы продолжаются исследования по выяснению ее причин, совершенствованию диагностики, лечения и профилактики. Известно, что подагра обычно возникает в связи с накоплением кристаллов моноурата натрия в суставах из-за высокого уровня сывороточной мочевой кислоты. В 2019 г. в журнале Annals of the Rheumatic Diseases были опубликованы новые данные о методах визуализации и клинической диагностики, основанные на принципах доказательной медицины. Сформулированные экспертами, они были приняты в виде консенсуса Европейской антиревматической лиги (EULAR). В настоящее время Американской коллегией ревматологов (ACR) разработаны новые стратегии лечения и профилактики подагры. 11 мая 2020 г. в журнале Arthritis & Rheumatology было представлено руководство по ведению больных подагрой, включая лечение острого приступа подагры, показания к уратснижающей терапии и инструкции по оптимальному ее применению, а также рекомендации по образу жизни и препаратам, которые часто назначаются пациентам с коморбидностью. Целью данного обзора является обобщение текущих знаний с акцентом на последних достижениях в алгоритме ведения пациентов с острой и хронической подагрой.

Gout, one of the most common forms of inflammatory arthritis, is characterized by severe joint pain, which often interferes with daily activities. In recent years, further research on its causes and on improving diagnosis, treatment and prevention has been ongoing. It is known that gout usually occurs due to the accumulation of sodium monourate crystals in joints due to high levels of serum uric acid. In 2019, the Annals of the Rheumatic Diseases journal published new data on imaging and clinical diagnostics methods based on the principles of evidence-based medicine. Formulated by experts, they were adopted as a consensus of the European League Against Rheumatism (EULAR). The American College of Rheumatology (ACR) has now developed new strategies to treat and prevent gout. On May 11, 2020, the Arthritis & Rheumatology Journal presented guidelines for the management of gout patients, including the treatment of acute gout attack, indications for urate-lowering therapy and instructions for its optimal use, as well as recommendations on lifestyle and drugs that are often prescribed to patients with comorbidity. The purpose of this review is to summarize current knowledge with a focus on recent advances in the algorithm for managing acute and chronic gout patients.

подаграгиперурикемияклинические рекомендациидиагностикадиетаобраз жизнипродукты питаниялечениеgouthyperuricemiaclinical recommendationsdiagnosisdietlifestylefood productstreatmentReferencesRichette P., Bardin T. Gout. Lancet. 2010;375(9711):318–328. doi: 10.1016/S0140-6736(09)60883-7.Richette P., Bardin T. Gout. Lancet. 2010;375(9711):318–328. doi: 10.1016/S0140-6736(09)60883-7.Nuki G., Simkin P.A. A concise history of gout and hyperuricemia and their treatment. Arthritis Research & Therapy. 2006;8(1):S1. doi: 10.1186/ar1906.Nuki G., Simkin P.A. A concise history of gout and hyperuricemia and their treatment. Arthritis Research & Therapy. 2006;8(1):S1. doi: 10.1186/ar1906.Громова М.А., Цурко В.В., Мелехина А.С. Рационально-обоснованный подход к питанию у больных подагрой. Клиницист. 2019;13(3–4):15–21. doi: 10.17650/1818-8338-2019-13-3-4-15-21.Gromova M.A., Tsurko V.V., Melekhina A.S. Rational approach to nutrition for patients with gout. Klinitsist = The Clinician. 2019;13(3–4):15–21. (In Russ.) doi: 10.17650/1818-8338-2019-13-3-4-15-21.Khanna D., Fitzgerald J.D., Khanna P.P., Bae S., Singh M.K., Neogi T. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care & Researches (Hoboken). 2012;64:1431–1446. doi: 10.1002/acr.21772.Khanna D., Fitzgerald J.D., Khanna P.P., Bae S., Singh M.K., Neogi T. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care & Researches (Hoboken). 2012;64:1431–1446. doi: 10.1002/acr.21772.Choi H.K. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol. 2010;22:165–172. doi: 10.1097/bor.0b013e328335ef38.Choi H.K. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol. 2010;22:165–172. doi: 10.1097/bor.0b013e328335ef38.De Vera M.A., Marcotte G., Rai S., Galo J.S., Bhole V. Medication adherence in gout: a systematic review. Arthritis Care & Researches (Hoboken). 2014;66(10):1551–1559. doi: 10.1002/acr.22336.De Vera M.A., Marcotte G., Rai S., Galo J.S., Bhole V. Medication adherence in gout: a systematic review. Arthritis Care & Researches (Hoboken). 2014;66(10):1551–1559. doi: 10.1002/acr.22336.Choi H.K., Liu S., Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis & Rheumatology. 2005;52:283–289. doi: 10.1002/art.20761.Choi H.K., Liu S., Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis & Rheumatology. 2005;52:283–289. doi: 10.1002/art.20761.Eckel R.H., Jakicic J.M., Ard J.D., de Jesus J.M., Houston Miller N., Hubbard V.S. et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129;25(2):S76–99. doi: 10.1161/01.cir.0000437740.48606.d1.Eckel R.H., Jakicic J.M., Ard J.D., de Jesus J.M., Houston Miller N., Hubbard V.S. et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129;25(2):S76–99. doi: 10.1161/01.cir.0000437740.48606.d1.Kalergis М., Sylvie S.L. Leung Yinko, Nedelcu R. Dairy Products and Prevention of Type 2 Diabetes: Implications for Research and Practice. Front Endocrinol (Lausanne). 2013;4:90. doi: 10.3389/fendo.2013.00090.Kalergis М., Sylvie S.L. Leung Yinko, Nedelcu R. Dairy Products and Prevention of Type 2 Diabetes: Implications for Research and Practice. Front Endocrinol (Lausanne). 2013;4:90. doi: 10.3389/fendo.2013.00090.Choi H.K., Atkinson K., Karlson E.W., Willett W., Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350:1093–1103. doi: 10.1056/nejmoa035700.Choi H.K., Atkinson K., Karlson E.W., Willett W., Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350:1093–1103. doi: 10.1056/nejmoa035700.Zgaga L., Theodoratou E., Kyle J., Farrington S.M., Agakov F., Tenesa A. et al. The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study. PLoS One. 2012;7:e38123. doi: 10.1371/journal.pone.0038123.Zgaga L., Theodoratou E., Kyle J., Farrington S.M., Agakov F., Tenesa A. et al. The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study. PLoS One. 2012;7:e38123. doi: 10.1371/journal.pone.0038123.Nielsena S.M., Zobbea K., Kristensena L.E., Christensen R. Nutritional recommendations for gout: An update from clinical epidemiology. Autoimmunity Reviews. 2018;17:1090–1096. doi: 10.1016/j.autrev.2018.05.008.Nielsena S.M., Zobbea K., Kristensena L.E., Christensen R. Nutritional recommendations for gout: An update from clinical epidemiology. Autoimmunity Reviews. 2018;17:1090–1096. doi: 10.1016/j.autrev.2018.05.008.Jordan K.M., Cameron J.S., Snaith M., Zhang W., Doherty M., Seckl J. et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the mana- gement of gout. Rheumatology (Oxford). 2007;46:1372–1374. doi: 10.1093/rheumatology/kem056a.Jordan K.M., Cameron J.S., Snaith M., Zhang W., Doherty M., Seckl J. et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the mana- gement of gout. Rheumatology (Oxford). 2007;46:1372–1374. doi: 10.1093/rheumatology/kem056a.Hui M., Carr A., Cameron S., Davenport G., Doherty M., Forrester H. et al. The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology (Oxford). 2017;56(7):e1–20. doi: 10.1093/rheumatology/kex156.Hui M., Carr A., Cameron S., Davenport G., Doherty M., Forrester H. et al. The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology (Oxford). 2017;56(7):e1–20. doi: 10.1093/rheumatology/kex156.Sautner J., Eichbauer-Sturm G., Gruber J., Puchner R., Spellitz P., Strehblow C. et al. Austrian nutrition and lifestyle recommendations for gout and hyperuricemia. Z Rheumatol. 2015;74(7):631–636. doi: 10.1007/s00393-015-1580-7.Sautner J., Eichbauer-Sturm G., Gruber J., Puchner R., Spellitz P., Strehblow C. et al. Austrian nutrition and lifestyle recommendations for gout and hyperuricemia. Z Rheumatol. 2015;74(7):631–636. doi: 10.1007/s00393-015-1580-7.Woutersen-Koch H., Wiersma T., Janssens H.J.E.M., Lagro B., Goudswaard L. Samenvatting van de standaard ‘Artritis’ van het Nederlands Huisartsen Genootschap. Ned Tijdschr Geneeskd. 2009;153. Available at: https://www.ntvg.nl/artikelen/samenvatting-van-de-standaard-%E2%80%98artritis%E2%80%99-van-het-nederlands-huisartsen-genootschap/volledig.Woutersen-Koch H., Wiersma T., Janssens H.J.E.M., Lagro B., Goudswaard L. Samenvatting van de standaard ‘Artritis’ van het Nederlands Huisartsen Genootschap. Ned Tijdschr Geneeskd. 2009;153. Available at: https://www.ntvg.nl/artikelen/samenvatting-van-de-standaard-%E2%80%98artritis%E2%80%99-van-het-nederlands-huisartsen-genootschap/volledig.Zhang W. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task Force of the standing Committee for international clinical studies including therapeutics (ESCISIT). Annals of the Rheumatic Diseases. 2006;65:1301–1311. doi: 10.1136/ard.2006.055251.Zhang W. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task Force of the standing Committee for international clinical studies including therapeutics (ESCISIT). Annals of the Rheumatic Diseases. 2006;65:1301–1311. doi: 10.1136/ard.2006.055251.Цурко В.В., Громова М.А. Общие принципы и основные рекомендации по ведению и лечению пациентов с подагрой по материалам обнов- ленных европейских рекомендаций. Consilium Medicum. 2017;19(12):20–24. doi: 10.26442/2075-1753_19.12.20-24.Tsurko V.V., Gromova M.A. General principles and guidelines for the management and treatment of patients with gout on the basis of updated European recommendations. Consilium Medicum. 2017;19(12):20–24. (In Russ.) doi: 10.26442/2075-1753_19.12.20-24.Pascual E., Doherty M. Aspiration of normal or asymptomatic pathological joints for diagnosis and research: indications, technique and success rate. Annals of the Rheumatic Diseases. 2009;68:3–7. doi: 10.1136/ard.2008.088328.Pascual E., Doherty M. Aspiration of normal or asymptomatic pathological joints for diagnosis and research: indications, technique and success rate. Annals of the Rheumatic Diseases. 2009;68:3–7. doi: 10.1136/ard.2008.088328.Pascual E., Sivera F. Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout. Annals of the Rheumatic Diseases. 2007;66:1056–1058. doi: 10.1136/ard.2006.060368.Pascual E., Sivera F. Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout. Annals of the Rheumatic Diseases. 2007;66:1056–1058. doi: 10.1136/ard.2006.060368.Graf S.W., Buchbinder R., Zochling J., Whittle S.L. The accuracy of methods for urate crystal detection in synovial fluid and the effect of sample handling: a systematic review. Clinical Rheumatology. 2013;32:225–232. doi: 10.1007/s10067-012-2107-0.Graf S.W., Buchbinder R., Zochling J., Whittle S.L. The accuracy of methods for urate crystal detection in synovial fluid and the effect of sample handling: a systematic review. Clinical Rheumatology. 2013;32:225–232. doi: 10.1007/s10067-012-2107-0.Kienhorst L.B.E., Janssens H.J.E.M., Eijgelaar R.S., Radstake T.R.D.J., van Riel P.L.C.M., Janssen M. The detection of monosodium urate crystals in synovial fluid after long-term and varying storage conditions. Joint Bone Spine. 2015;82:470–471. doi: 10.1016/j.jbspin.2014.10.020.Kienhorst L.B.E., Janssens H.J.E.M., Eijgelaar R.S., Radstake T.R.D.J., van Riel P.L.C.M., Janssen M. The detection of monosodium urate crystals in synovial fluid after long-term and varying storage conditions. Joint Bone Spine. 2015;82:470–471. doi: 10.1016/j.jbspin.2014.10.020.Malik A., Schumacher H.R., Dinnella J.E., Clayburne G.M. Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. Journal of Clinical Rheumatology. 2009;15:22–24. doi: 10.1097/rhu.0b013e3181945b79.Malik A., Schumacher H.R., Dinnella J.E., Clayburne G.M. Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. Journal of Clinical Rheumatology. 2009;15:22–24. doi: 10.1097/rhu.0b013e3181945b79.Zufferey P., Valcov R., Fabreguet I., Dumusc A., Omoumi P., So A. A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis. Arthritis Research & Therapy. 2015; 17(1):188. doi: 10.1186/s13075-015-0701-7.Zufferey P., Valcov R., Fabreguet I., Dumusc A., Omoumi P., So A. A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis. Arthritis Research & Therapy. 2015; 17(1):188. doi: 10.1186/s13075-015-0701-7.Ogdie A., Taylor W.J., Weatherall M., Fransen J., Jansen T.L., Neogi T. et al. Imaging modalities for the classification of gout: systematic literature review and meta-analysis. Annals of the Rheumatic Diseases. 2015;74:1868–1874. doi: 10.1136/annrheumdis-2014-205431.Ogdie A., Taylor W.J., Weatherall M., Fransen J., Jansen T.L., Neogi T. et al. Imaging modalities for the classification of gout: systematic literature review and meta-analysis. Annals of the Rheumatic Diseases. 2015;74:1868–1874. doi: 10.1136/annrheumdis-2014-205431.Racine D., Ott J., Andreisek G., Omoumi P., Verdun F., Becce F. Dual-energy CT: basic principles, technical approaches, and applications in musculoskeletal imaging (Part 1). Seminars in musculoskeletal radiology. 2015;19(5):431–437. doi: 10.1055/s-0035-1569253.Racine D., Ott J., Andreisek G., Omoumi P., Verdun F., Becce F. Dual-energy CT: basic principles, technical approaches, and applications in musculoskeletal imaging (Part 1). Seminars in musculoskeletal radiology. 2015;19(5):431–437. doi: 10.1055/s-0035-1569253.Sapsford M., Gamble G.D., Aati O., Knight J., Horne A., Doyle A.J., Dalbeth N. Relationship of bone erosion with the urate and soft tissue components of the tophus in gout: a dual energy computed tomography study. Rheumatology. 2017;56:129–133. doi: 10.1093/rheumatology/kew383.Sapsford M., Gamble G.D., Aati O., Knight J., Horne A., Doyle A.J., Dalbeth N. Relationship of bone erosion with the urate and soft tissue components of the tophus in gout: a dual energy computed tomography study. Rheumatology. 2017;56:129–133. doi: 10.1093/rheumatology/kew383.Towiwat P., Doyle A.J., Gamble G.D., Tan P., Aati O., Horne A. et al. Urate crystal deposition and bone erosion in gout: ’inside-out’ or ’outside-in’? A dual-energy computed tomography study. Arthritis Research & Therapy. 2016;18(1):208. doi: 10.1186/s13075-016-1105-z.Towiwat P., Doyle A.J., Gamble G.D., Tan P., Aati O., Horne A. et al. Urate crystal deposition and bone erosion in gout: ’inside-out’ or ’outside-in’? A dual-energy computed tomography study. Arthritis Research & Therapy. 2016;18(1):208. doi: 10.1186/s13075-016-1105-z.Bayat S., Aati O., Rech J., Sapsford M., Cavallaro A., Lell M. et al. Development of a dual-energy computed tomography scoring system for measurement of urate deposition in gout. Arthritis Care & Researches. 2016;68:769–775. doi: 10.1002/acr.22754.Bayat S., Aati O., Rech J., Sapsford M., Cavallaro A., Lell M. et al. Development of a dual-energy computed tomography scoring system for measurement of urate deposition in gout. Arthritis Care & Researches. 2016;68:769–775. doi: 10.1002/acr.22754.Carter J.D., Kedar R.P., Anderson S.R., Osorio A.H., Albritton N.L., Gnanashanmugam S. et al. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology. 2009;48:1442–1446. doi: 10.1093/rheumatology/kep278.Carter J.D., Kedar R.P., Anderson S.R., Osorio A.H., Albritton N.L., Gnanashanmugam S. et al. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology. 2009;48:1442–1446. doi: 10.1093/rheumatology/kep278.Buckens C.F., Terra M.P., Maas M. Computed tomography and MR imaging in Crystalline-Induced arthropathies. RadiolClin North Am. 2017;55:1023–1034. doi: 10.1016/j.rcl.2017.04.008.Buckens C.F., Terra M.P., Maas M. Computed tomography and MR imaging in Crystalline-Induced arthropathies. RadiolClin North Am. 2017;55:1023–1034. doi: 10.1016/j.rcl.2017.04.008.Dalbeth N., Aati O., Kalluru R., Gamble G.D., Horne A., Doyle A.J., McQueen F.M. Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study. Annals of the Rheumatic Diseases. 2015;74:1030–1036. doi: 10.1136/annrheumdis-2013-204273.Dalbeth N., Aati O., Kalluru R., Gamble G.D., Horne A., Doyle A.J., McQueen F.M. Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study. Annals of the Rheumatic Diseases. 2015;74:1030–1036. doi: 10.1136/annrheumdis-2013-204273.Choi H.K., Soriano L.C., Zhang Y., Rodriguez L.A.G. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012;344:d8190. doi: 10.1136/bmj.d8190.Choi H.K., Soriano L.C., Zhang Y., Rodriguez L.A.G. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012;344:d8190. doi: 10.1136/bmj.d8190.Громова М.А., Цурко В.В., Аверинова С.Г., Кашкадаева А.В., Захарова Т.В. Радионуклидный скрининг и мониторинг функционального состояния мочевой системы для прогнозирования риска хронической болезни почек у больных подагрой (Технология СЭНС-КР). Клиническая геронтология. 2019;25(3–4):5–32. doi: 10.26347/1607-2499201903-04025-032.Gromova M.A., Tsurko V.V., Averinova S.G., Kashkadaeva A.V., Zakharova T.V. Radionuclide screening and monitoring of the functional state of the urinary system to predict the risk of chronic kidney disease in patients with gout (SENS-KR technology). Klinicheskaya gerontologiya = Clinical Gerontology. 2019;25(3–4):5–32. (In Russ.) doi: 10.26347/1607-2499201903-04025-032.Gromova M., Tsurko V., Kashkadayeva A., Averinova S., Aliokhin A. Assessment of the kidneys and urinary tract dysfunctions that increase the risk of developing chronic kidney disease in patients with gout based on complex renal scintigraphy. Annals of the Rheumatic Diseases. 2019;78(2):1903–1904. doi: 10.1136/annrheumdis-2019-eular.755.Gromova M., Tsurko V., Kashkadayeva A., Averinova S., Aliokhin A. Assessment of the kidneys and urinary tract dysfunctions that increase the risk of developing chronic kidney disease in patients with gout based on complex renal scintigraphy. Annals of the Rheumatic Diseases. 2019;78(2):1903–1904. doi: 10.1136/annrheumdis-2019-eular.755.Kuo C.F., Grainge M.J., Mallen C., Zhang W., Doherty M. Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England. JAMA. 2015;312(24):2684–2685. doi: 10.1001/jama.2014.14484.Kuo C.F., Grainge M.J., Mallen C., Zhang W., Doherty M. Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England. JAMA. 2015;312(24):2684–2685. doi: 10.1001/jama.2014.14484.FitzGerald J.D., Dalbeth N., Mikuls T., Brignardello-Petersen R., Guyatt G., Abeles A.M. et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care & Researches (Hoboken). 2020;72(6):744–760. doi: 10.1002/acr.24180.FitzGerald J.D., Dalbeth N., Mikuls T., Brignardello-Petersen R., Guyatt G., Abeles A.M. et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care & Researches (Hoboken). 2020;72(6):744–760. doi: 10.1002/acr.24180.Yang M., Wang H.T., Zhao M., Meng W.B., Ou J.Q., He J.H. et al. Network Meta- Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury. Medicine (Baltimore). 2015;94(40):e1592. doi: 10.1097/md.0000000000001592.Yang M., Wang H.T., Zhao M., Meng W.B., Ou J.Q., He J.H. et al. Network Meta- Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury. Medicine (Baltimore). 2015;94(40):e1592. doi: 10.1097/md.0000000000001592.Arfè A., Scotti L., Varas-Lorenzo C., Nicotra F., Zambon A., Kollhorst B. et al. Nonsteroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857. doi: 10.1136/bmj.i4857.Arfè A., Scotti L., Varas-Lorenzo C., Nicotra F., Zambon A., Kollhorst B. et al. Nonsteroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857. doi: 10.1136/bmj.i4857.Varas-Lorenzo C., Riera-Guardia N., Calingaert B., Salvo F., Nicotra F., Sturkenboom M., Perez-Gutthann S. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysisof observational studies. Pharmacoepidemiol Drug Saf. 2013;22(6):559–570. doi: 10.1002/pds.3437.Varas-Lorenzo C., Riera-Guardia N., Calingaert B., Salvo F., Nicotra F., Sturkenboom M., Perez-Gutthann S. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysisof observational studies. Pharmacoepidemiol Drug Saf. 2013;22(6):559–570. doi: 10.1002/pds.3437.Asghar W., Jamali F. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. Inflammopharmacology. 2015;23(1):1–16. doi: 10.1007/s10787-014-0225-9.Asghar W., Jamali F. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. Inflammopharmacology. 2015;23(1):1–16. doi: 10.1007/s10787-014-0225-9.Ungprasert P., Matteson E.L., Thongprayoon C. Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke. Stroke. 2016;47(2):356–364. doi: 10.1161/strokeaha.115.011678.Ungprasert P., Matteson E.L., Thongprayoon C. Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke. Stroke. 2016;47(2):356–364. doi: 10.1161/strokeaha.115.011678.Dasgeb B., Kornreich D., McGuinn K., Okon L., Brownell I., Sackett D.L. Colchicine: an ancient drug with novel applications. Br J Dermatol. 2018;178(2):350–356. doi: 10.1111/bjd.15896.Dasgeb B., Kornreich D., McGuinn K., Okon L., Brownell I., Sackett D.L. Colchicine: an ancient drug with novel applications. Br J Dermatol. 2018;178(2):350–356. doi: 10.1111/bjd.15896.Schlesinger N., Mysler E., Lin H., De Meulenmeester M., Rovensky J., Arulmani U. et al. Canakinumab Reduces The Risk Of Acute Gouty Arthritis Flares During Initiation Of Allopurinol Therapy: Results Of A Double-blind, Randomised Study. Journal of Allergy and Clinical Immunology. 2011;127(2):AB227. doi: 10.1016/j.jaci.2010.12.902.Schlesinger N., Mysler E., Lin H., De Meulenmeester M., Rovensky J., Arulmani U. et al. Canakinumab Reduces The Risk Of Acute Gouty Arthritis Flares During Initiation Of Allopurinol Therapy: Results Of A Double-blind, Randomised Study. Journal of Allergy and Clinical Immunology. 2011;127(2):AB227. doi: 10.1016/j.jaci.2010.12.902.Richette P., Doherty M., Pascual E., Barskova V., Becce F., Castañeda-Sanabria J. et al. Updated EULAR evidence-based recommendations for the management of gout. pii: annrheumdis-2016-209707. Annals of the Rheumatic Diseases. Ann Rheum Dis. 2017;76(1):29–42. doi: 10.1136/annrheumdis-2016-209707.Richette P., Doherty M., Pascual E., Barskova V., Becce F., Castañeda-Sanabria J. et al. Updated EULAR evidence-based recommendations for the management of gout. pii: annrheumdis-2016-209707. Annals of the Rheumatic Diseases. Ann Rheum Dis. 2017;76(1):29–42. doi: 10.1136/annrheumdis-2016-209707.Громова М.А., Цурко В.В., Кисляк О.А., Малышева Н.В. Оценка 12-недельной уратснижающей терапии аллопуринолом в сочетании с нестероидным противовоспалительным препаратом мелоксикам у больных с хронической подагрой. Терапевтический архив. 2020. doi: 10.26442/00403660.2020.06.000649.Gromova M.A., Tsurko V.V., Kislyak O.A., Malysheva N.V. Evaluation of a 12-week allopurinol-lowering therapy in combination with the non-steroidal anti-inflammatory drug meloxicam in patients with chronic gout. Terapevticheskiy arkhiv = Therapeutic archive. 2020. (In Russ.) doi: 10.26442/00403660.2020.06.000649.Цурко В.В., Громова М.А. Рационально-обоснованный подход к лечению подагры с учетом дебюта, течения и сочетанной патологии по материалам рекомендаций Европейской антиревматической лиги (EULAR 2016). Терапевтический архив. 2017;89(12):233–237. doi: 10.17116/terarkh20178912233-237.Tsurko V.V., Gromova M.A. A rationally grounded approach to treating gout with regard to its onset and course and the presence of comorbidity according to the European League against Rheumatism (EULAR 2016) recommendations. Terapevticheskiy arkhiv = Therapeutic archive. 2017;89(12):233–237. (In Russ.) doi: 10.17116/terarkh20178912233-237.Chung W.H., Chang W.C., Stocker S.L., Juo C.G., Graham G.G., Lee M.H. et al. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Annals of the Rheumatic Diseases. 2015;74(12):2157–2164. doi: 10.1136/annrheumdis-2014-205577.Chung W.H., Chang W.C., Stocker S.L., Juo C.G., Graham G.G., Lee M.H. et al. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Annals of the Rheumatic Diseases. 2015;74(12):2157–2164. doi: 10.1136/annrheumdis-2014-205577.Juge P.A., Truchetet M.E., Pillebout E., Ottaviani S., Vigneau C., Loustau C. et al. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers. Joint Bone Spine. 2017;84(5):595–598. doi: 10.1016/j.jbspin.2016.09.020.Juge P.A., Truchetet M.E., Pillebout E., Ottaviani S., Vigneau C., Loustau C. et al. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers. Joint Bone Spine. 2017;84(5):595–598. doi: 10.1016/j.jbspin.2016.09.020.White W.B., Saag K.G., Becker M.A., Borer J.S., Gorelick P.B., Whelton A. et al. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. N Engl J Med. 2018;378(13):1200–1210. doi: 10.1056/nejmoa1710895.White W.B., Saag K.G., Becker M.A., Borer J.S., Gorelick P.B., Whelton A. et al. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. N Engl J Med. 2018;378(13):1200–1210. doi: 10.1056/nejmoa1710895.Насонов Е.Л. (ред.). Российские клинические рекомендации. Ревматология. М.: ГЭОТАР-Медиа; 2017. 464 с. Режим доступа: http://www.geotar.ru/lots/NF0005151.html.Nasonov E.L. (ed.). Russian clinical guidelines. Rheumatology. Moscow: GEOTARMedia; 2017. 464 p. (In Russ.) Available at: http://www.geotar.ru/lots/NF0005151.html

The authors declare that there are no conflicts of interest present.